Rival Covid-19 jab developers face off in High Court patent trial
by Tom Pilgrim
Apr 23, 2024
2 minutes
Rival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial over life-saving vaccine technology patents began.
Pharmaceutical giant and drug manufacturer BioNTech are locked in a legal dispute with vaccine maker Moderna over the use of messenger RNA (mRNA) technology in coronavirus jabs amid parallel litigation, the and other countries.
You’re reading a preview, subscribe to read more.
Start your free 30 days